Bright Minds Biosciences has become one of the most discussed names in biotechnology companies. It’s a start-up in the news because of its different approach for medicines to cure mental health. Mental illness is an age-old issue, but most of us don’t take it seriously. So the research and development on drugs to cure mental illness are less than the requirements. Patients with mental health issues have to depend on the first-generation medicine of antipsychotics.
With time the antipsychotic has become better, but still, it has side effects on patients. Bright Minds come up with the idea of developing second-generation medicines to cure mental illness. The main idea behind developing the new generation medicines is to offer a side effect free treatment to the patients. Read on further to know how the people will get the benefits of these new medicines;
Why Bright Mind’s Approach Sounds Promising?
The pandemic has brought a drastic change in people’s lives all around the world. As the pandemic sweeps in the world, the risks of mental illness got higher. According to a study, during the pandemic, the depression symptoms were more than threefold higher. So the drug developing companies like Bright Minds have to work to develop more effective drugs.
One of the biggest issues with first-generation medicines to cure mental health is their side effects. The medicines heal the patients slowly. They also experience a drastic change in their weight, eating habits, sleeping routine, or mood swings.
The first-generation antipsychotic starts working in few hours, but they need six weeks to help the patients. Moreover, the medicines work on symptoms and don’t cure the root cause of mental illness. So the world and doctors need a second generation of medicines to cure mental illness and other related issues.
Bright Minds Bioscience Work for Next Generation Medicines
In the present scenario, when mental illness has become one of the biggest challenges for the health sector, the Bright Minds Biosciences concept looks promising. The biotechnology start-up has a great team with decades of experience in the serotonergic system. The company is using the experience to develop next-generation medicines. Bright Minds claims that the medicines will be more effective and have no side effects.
The serotonergic system is one of the oldest and most complicated systems of the brain. It’s like a mystery of the human brain that is yet to be solved. A team of experts in Bright Minds is working on it. The serotonergic system is a collection of neurons. It plays a crucial role in different psychiatric disorders like major depression,
schizophrenia, and anxiety disorder. To handle this kind of mental illness, that company is working on next-generation serotonergic drugs.
The professionals in Bright Minds understand the effect of a particular receptor on the human body. So the approach of the biotechnology company is to change the existing molecule in drugs. According to the concept of Bright Minds, the next-generation drugs will be more effective as they will treat the targeted receptors. Therefore, the side effects of the medicines will be minimum or none.
